Semaphorin 7A

Semaphorin 7A 製品リスト

  • 属性

    Protein (1)

  • 製品ライブラリ

    オンライン (1)

  • Human (1)

  • タグ

    His Tag & Avi Tag (1)

  • マーカー

    Biotin-labeled (1)

製品番号発現システム製品説明タンパク質の構造純度特性
SEA-H82E7
Human
HEK293
Biotinylated Human Semaphorin 7A / SEMA7A Protein, His,Avitag™
総数量1
  • 1

Semaphorin 7Aバックグランド

This gene encodes a member of the semaphorin family of proteins. The encoded preproprotein is proteolytically processed to generate the mature glycosylphosphatidylinositol (GPI)-anchored membrane glycoprotein. The encoded protein is found on activated lymphocytes and erythrocytes and may be involved in immunomodulatory and neuronal processes. The encoded protein carries the John Milton Hagen (JMH) blood group antigens. Mutations in this gene may be associated with reduced bone mineral density (BMD). Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Donaperminogene seltoplasmid (ViroMed)VM202-Stent; VM202-PAD; pCK-HGF-X7; VM202-DPN; VM-202CAD; VM-202ALS; VM202-RY; VM-202; NL-003; HGF-X7Phase 3 ClinicalViromedMyocardial Ischemia; Diabetic Foot; Charcot-Marie-Tooth Disease; Intermittent Claudication; Myocardial Infarction; Arterial Occlusive Diseases; Peripheral Vascular Diseases; Diabetic Neuropathies; Ischemia; Diabetic peripheral neuropathy; Ulcer; Amyotrophic Lateral Sclerosis; Peripheral Arterial Disease
詳細
FosgonimetonATH-1017; NDX-1017Phase 3 ClinicalM3 BiotechnologyAlzheimer Disease; Lewy Body Disease
詳細
FiclatuzumabAV-299; SCH-900105Phase 3 ClinicalAveoMultiple Myeloma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Lymphoma; Leukemia, Myeloid, Acute; Lung Neoplasms; Oropharyngeal Neoplasms; Cholangiocarcinoma; Respiratory Tract Neoplasms; Solid tumours; Colonic Neoplasms; Pancreatic Neoplasms; Small Cell Lung Carcinoma; Glioblastoma; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Basal Cell; Head and Neck Neoplasms; Liver Neoplasms
詳細
MP-0250MP-0250Phase 2 ClinicalMolecular Partners AgNeoplasms; Multiple Myeloma; Carcinoma, Non-Small-Cell Lung
詳細
YYB-101NOV-1105; YYB-101Phase 2 ClinicalYooyoungSolid tumours; Colorectal Neoplasms
詳細
ATH-1020ATH-1020Phase 1 ClinicalAthira Pharma Inc
詳細
Microbiome-optimized autologous stem cell therapy (Biotech Holdings)ClinicalBiotech HoldingsPeripheral Vascular Diseases
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Beperminogene perplasmidDS-992; AMG-0001; TREAT-HGF; AMG-0001-01ApprovedAnges Mg, Osaka UniversityCollategeneJapanIschemia; Peripheral Arterial Diseasenull, Anges Inc2019-03-01Arterial Occlusive Diseases; Peripheral Vascular Diseases; Atherosclerosis; Vascular Diseases; Foot Ulcer; Ischemia; Ulcer; Peripheral Arterial Disease
詳細
  • 製品リスト
  • 市販薬剤に関する情報
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8